Neurophysiological Markers for Prediction of Rehabilitation Outcomes After Ischemic Stroke

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-65
SponsorMoscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine

About this trial

The goal of this randomized controlled study is to develop and validate an integrated neurophysiological model for predicting rehabilitation potential in patients with ischemic stroke. The study focuses on identifying objective markers of brain activity associated with motor preparation and recovery.

The project includes two stages. First, healthy volunteers will participate in experimental motor and mental tasks to establish reference patterns of brain activity using electroencephalography and transcranial magnetic stimulation. These data will be used to define stable neurophysiological markers of motor network function.

In the second stage, patients in the acute and early recovery phases after ischemic stroke will be randomly assigned to receive either active intermittent theta-burst stimulation of the motor cortex or a sham procedure, in addition to standard rehabilitation. Brain activity and clinical motor function will be assessed before and after the intervention.

The study aims to determine which neurophysiological measures are sensitive to neuromodulation and are associated with clinical improvement, in order to construct a predictive model of rehabilitation outcome.

Participants will \[describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items\].

Eligibility criteria

Qualifiers

First-ever ischemic stroke confirmed by CT/MRI

5 days - 6 months post-stroke

Age 40-65

MoCA ≥20

Disqualifiers

Implanted electronic devices

Epilepsy

Severe cardiac arrhythmias

Intracranial aneurysm

Trial design

Treatments tested in this trial

  • Intermittent Theta Burst Stimulation
  • Sham Intermittent Theta Burst Stimulation

Treatment groups

120 Participants
are divided into 2 treatment groups